|
1
|
Klein R, Klein BE, Moss SE and
Cruickshanks KJ: The Wisconsin Epidemiologic Study of Diabetic
Retinopathy: XVII. The 14-year incidence and progression of
diabetic retinopathy and associated risk factors in type 1
diabetes. Ophthalmology. 105:1801–1815. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wong TY, Klein R, Islam FM, Cotch MF,
Folsom AR, Klein BE, Sharrett AR and Shea S: Diabetic retinopathy
in a multi-ethnic cohort in the United States. Am J Ophthalmol.
141:446–455. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ng DP: Human genetics of diabetic
retinopathy: Ccurrent perspectives. J Ophthalmol.
2010:1725932010.
|
|
4
|
Mohamed Q, Gillies MC and Wong TY:
Management of diabetic retinopathy: Aa systematic review. JAMA.
298:902–916. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Todd JA, Walker NM, Cooper JD, Smyth DJ,
Downes K, Plagnol V, Bailey R, Nejentsev S, Field SF, Payne F, et
al: Genetics of Type 1 Diabetes in Finland; Wellcome Trust Case
Control Consortium: Robust associations of four new chromosome
regions from genome-wide analyses of type 1 diabetes. Nat Genet.
39:857–864. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Brucklacher RM, Patel KM, VanGuilder HD,
Bixler GV, Barber AJ, Antonetti DA, Lin CM, LaNoue KF, Gardner TW,
Bronson SK and Freeman WM: Whole genome assessment of the retinal
response to diabetes reveals a progressive neurovascular
inflammatory response. BMC Med Genomics. 1:262008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Costa V, Gallo MA, Letizia F, Aprile M,
Casamassimi A and Ciccodicola A: PPARG: Gene expression regulation
and next-generation sequencing for unsolved issues. PPAR Res.
2010:4091682010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lorenzi M and Gerhardinger C: Early
cellular and molecular changes induced by diabetes in the retina.
Diabetologia. 44:791–804. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Warpeha KM and Chakravarthy U: Molecular
genetics of microvascular disease in diabetic retinopathy. Eye
(Lond). 17:305–311. 2003. View Article : Google Scholar
|
|
10
|
Ray D, Mishra M, Ralph S, Read I, Davies R
and Brenchley P: Association of the VEGF gene with proliferative
diabetic retinopathy but not proteinuria in diabetes. Diabetes.
53:861–864. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kumaramanickavel G, Ramprasad VL, Sripriya
S, Upadyay NK, Paul PG and Sharma T: Association of Gly82Ser
polymorphism in the RAGE gene with diabetic retinopathy in type II
diabetic Asian Indian patients. J Diabetes Complications.
16:391–394. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Awata T, Inoue K, Kurihara S, Ohkubo T,
Watanabe M, Inukai K, Inoue I and Katayama S: A common polymorphism
in the 5′-untranslated region of the VEGF gene is associated with
diabetic retinopathy in type 2 diabetes. Diabetes. 51:1635–1639.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Y, Ng MC, Lee SC, So WY, Tong PC,
Cockram CS, Critchley JA and Chan JC: Phenotypic heterogeneity and
associations of two aldose reductase gene polymorphisms with
nephropathy and retinopathy in type 2 diabetes. Diabetes Care.
26:2410–2415. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Suganthalakshmi B, Anand R, Kim R,
Mahalakshmi R, Karthikprakash S, Namperumalsamy P and Sundaresan P:
Association of VEGF and eNOS gene polymorphisms in type 2 diabetic
retinopathy. Mol Vis. 12:336–341. 2006.PubMed/NCBI
|
|
15
|
Beránek M, Kanková K, Benes P,
Izakovicová-Hollá L, Znojil V, Hájek D, Vlková E and Vácha J:
Polymorphism R25P in the gene encoding transforming growth
factor-beta (TGF-beta1) is a newly identified risk factor for
proliferative diabetic retinopathy. Am J Med Genet. 109:278–283.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lam HC, Lee JK, Lu CC, Chu CH, Chuang MJ
and Wang MC: Role of endothelin in diabetic retinopathy. Curr Vasc
Pharmacol. 1:243–250. 2003. View Article : Google Scholar
|
|
17
|
Santos KG, Tschiedel B, Schneider J, Souto
K and Roisenberg I: Diabetic retinopathy in Euro-Brazilian type 2
diabetic patients: relationship with polymorphisms in the aldose
reductase, the plasminogen activator inhibitor-1 and the
methylenetetrahydrofolate reductase genes. Diabetes Res Clin Pract.
61:133–136. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Amano S, Yamagishi S, Koda Y, Tsuneoka M,
Soejima M, Okamoto T, Inagaki Y, Yamada K and Kimura H:
Polymorphisms of sorbitol dehydrogenase (SDH) gene and
susceptibility to diabetic retinopathy. Med Hypotheses. 60:550–551.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yoshioka K, Yoshida T, Takakura Y, Umekawa
T, Kogure A, Toda H and Yoshikawa T: Relation between polymorphisms
G1704T and G82S of rage gene and diabetic retinopathy in Japanese
type 2 diabetic patients. Intern Med. 44:417–421. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Edgar R, Domrachev M and Lash AE: Gene
Expression Omnibus: NCBI gene expression and hybridization array
data repository. Nucleic Acids Res. 30:207–210. 2002. View Article : Google Scholar :
|
|
21
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Aarchive for functional
genomics data set-update. Nucleic Acids Res. 41:D991–D995. 2013.
View Article : Google Scholar
|
|
22
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES, et al: Gene set enrichment analysis: a
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
He K, Chen Z, Ma Y and Pan Y:
Identification of high-copper-responsive target pathways in Atp7b
knockout mouse liver by GSEA on microarray data sets. Mamm Genome.
22:703–713. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao H, Wang Q, Bai C, He K and Pan Y: A
cross-study gene set enrichment analysis identifies critical
pathways in endometriosis. Reprod Biol Endocrinol. 7:942009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gautier L, Cope L, Bolstad BM and Irizarry
RA: affy - analysis of Affymetrix GeneChip data at the probe level.
Bioinformatics. 20:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chiaretti S, Li X, Gentleman R, Vitale A,
Vignetti M, Mandelli F, Ritz J and Foa R: Gene expression profile
of adult T-cell acute lymphocytic leukemia identifies distinct
subsets of patients with different response to therapy and
survival. Blood. 103:2771–2778. 2004. View Article : Google Scholar
|
|
27
|
Gotea V and Ovcharenko I: DiRE:
Iidentifying distant regulatory elements of co-expressed genes.
Nucleic Acids Res. 36:W133–W139. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ma JH, Li J, Wang JJ and Zhang SX: X-box
binding protein 1 (XBP1) is a crucial regulator of endothelial
tight junction and protects the blood-retinal barrier in diabetic
retinopathy. Invest Ophthalmol Vis Sci. 55:22532014.
|
|
29
|
Akhtar S, Almubrad T, Bron AJ, Yousif MH,
Benter IF and Akhtar S: Role of epidermal growth factor receptor
(EGFR) in corneal remodelling in diabetes. Acta Ophthalmol.
87:881–889. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
McClintock JL and Ceresa BP: Transforming
growth factor-{alpha} enhances corneal epithelial cell migration by
promoting EGFR recycling. Invest Ophthalmol Vis Sci. 51:3455–3461.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Humar R, Kiefer FN, Berns H, Resink TJ and
Battegay EJ: Hypoxia enhances vascular cell proliferation and
angiogenesis in vitro via rapamycin (mTOR)-dependent signaling.
FASEB J. 16:771–780. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cai J, Ahmad S, Jiang WG, Huang J, Kontos
CD, Boulton M and Ahmed A: Activation of vascular endothelial
growth factor receptor-1 sustains angiogenesis and Bcl-2 expression
via the phosphatidylinositol 3-kinase pathway in endothelial cells.
Diabetes. 52:2959–2968. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Klein R, Lee KE, Gangnon RE and Klein BE:
The 25-year incidence of visual impairment in type 1 diabetes
mellitus the wisconsin epidemiologic study of diabetic retinopathy.
Ophthalmology. 117:63–70. 2010. View Article : Google Scholar
|
|
34
|
Wang QJ: PKD at the crossroads of DAG and
PKC signaling. Trends Pharmacol Sci. 27:317–323. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lemberger T, Desvergne B and Wahli W:
Peroxisome proliferator-activated receptors: a nuclear receptor
signaling pathway in lipid physiology. Annu Rev Cell Dev Biol.
12:335–363. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hihi AK, Michalik L and Wahli W: PPARs:
Transcriptional effectors of fatty acids and their derivatives.
Cell Mol Life Sci. 59:790–798. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Berger J and Moller DE: The mechanisms of
action of PPARs. Annu Rev Med. 53:409–435. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Song MK, Roufogalis BD and Huang TH:
Modulation of diabetic retinopathy pathophysiology by natural
medicines through PPAR-γ-related pharmacology. Br J Pharmacol.
165:4–19. 2012. View Article : Google Scholar :
|
|
39
|
Chen Y, Hu Y, Lin M, Jenkins AJ, Keech AC,
Mott R, Lyons TJ and Ma JX: Therapeutic effects of PPARα agonists
on diabetic retinopathy in type 1 diabetes models. Diabetes.
62:261–272. 2013. View Article : Google Scholar
|
|
40
|
Massagué J and Wotton D: Transcriptional
control by the TGF-β/Smad signaling system. EMBO J. 19:1745–1754.
2000. View Article : Google Scholar
|
|
41
|
Derynck R and Zhang YE: Smad-dependent and
Smad-independent pathways in TGF-β family signalling. Nature.
425:577–584. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kim ES, Kim MS and Moon A:
TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38
MAPK, but not ERK signaling in MCF10A human breast epithelial
cells. Int J Oncol. 25:1375–1382. 2004.PubMed/NCBI
|
|
43
|
Yingchuan F, Chuntao L, Hui C and Jianbin
H: Increased expression of TGF-β1 and Smad 4 on oxygen-induced
retinopathy in neonatal mice. Retinal Degenerative Diseases.
Springer-Verlag; New York, NY: pp. 71–77. 2010, View Article : Google Scholar
|
|
44
|
Gerhardinger C, Dagher Z, Sebastiani P,
Park YS and Lorenzi M: The transforming growth factor-β pathway is
a common target of drugs that prevent experimental diabetic
retinopathy. Diabetes. 58:1659–1667. 2009. View Article : Google Scholar : PubMed/NCBI
|
